Skip to main content
. 2021 Aug 28;13(9):3000. doi: 10.3390/nu13093000

Figure 13.

Figure 13

Effect of tested compounds on the tumor burden in BALB/c nude mice with HepG2 cancer xenografts. Control mice are shown in Panel (A), while the Xanthohumol-treated (40 mg/kg b.w.) group is presented in panel (B). The group treated with PEITC (15 mg/kg b.w.) on panel (C) and the group treated with Xanthohumol + PEITC on panel (D). The series of photographs show luminescence at days 4, 11, and 16, as is presented in panel (E). The luminescence signal measured in each mice (marked with ear tags’ number) is also shown in Figure 13.